
Ajros Pharmaceuticals Private Limited
About Ajros Pharmaceuticals Private Limited
Data last updated:
Ajros Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 08 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24299BR2021PTC049955. Its GSTIN is 10AAUCA6173F1ZP (Bihar).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mohammad Seraj Alam and Zoya Perween.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Md Suleman Moola Sai Ki Bag, Patna, Bihar, India – 800008.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.69 Lakh, a decline of 52% compared to the previous year. For the same year it recorded a net profit of ₹2,453 (net margin 0.7%) and EBITDA of ₹13,449 (EBITDA margin 3.6%). Revenue has declined at a compounded annual rate (CAGR) of 23% over three years.
The company has about 1 employee on its provident fund (EPFO) records.
Company details
Contact details
Ajros Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address is in the company report.
- Email
- Registered AddressMd Suleman Moola Sai Ki Bag, Patna, Bihar, India – 800008
- IndustryHealthcare, Hospitals
To see the full contact details of Ajros Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ajros Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ajros Pharmaceuticals Private Limited, buy the company report.
Financials of Ajros Pharmaceuticals Private Limited
FY 2025 filings availableAjros Pharmaceuticals Private Limited reported revenue of ₹3.69 Lakh (down 52% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 23% over three years, including a 52% fall in the latest year. EBITDA rose 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13,449 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,453 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ajros Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ajros Pharmaceuticals Private Limited
Ajros Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammad Seraj Alam | Director | 21 Feb 2025 | 1 Years 9 Months | Current |
| Zoya Perween | Director | 21 Feb 2025 | 1 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Ajros Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ajros Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ajros Pharmaceuticals Private Limited has a workforce of 1 employees on its EPFO records as of Apr 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 1 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 |
To see the full employee and EPFO history of Ajros Pharmaceuticals Private Limited, buy the company report.
GST
Ajros Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAUCA6173F1ZP | Bihar | Active | 11 Jan 2022 |
To see the full GST registrations and return filing status of Ajros Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ajros Pharmaceuticals Private Limited has 4 board changes on record since 2025: 2 appointments and 2 cessations. The latest: Mohammad Ahasan ceased to be Director on 03 Mar 2025.
Frequently asked questions
Ajros Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in hospitals, within the healthcare industry. It was incorporated on 08 January 2021 (5+ years old) and is registered under CIN U24299BR2021PTC049955.
Ajros Pharmaceuticals has 2 current directors:
- Mohammad Seraj Alam - Director
- Zoya Perween - Director
The latest financial statements of Ajros Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Ajros Pharmaceuticals is 10AAUCA6173F1ZP, registered in Bihar.
The CIN (Corporate Identification Number) of Ajros Pharmaceuticals is U24299BR2021PTC049955. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ajros Pharmaceuticals was incorporated on 08 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Patna.
Mohammad Ahasan ceased to be Director on 03 Mar 2025. Mohammad Jayed Alam ceased to be Director on 03 Mar 2025. Mohammad Seraj Alam was appointed as Director on 21 Feb 2025. Ajros Pharmaceuticals has 4 board changes on record in total.
The registered office of Ajros Pharmaceuticals is at Md Suleman Moola Sai Ki Bag, Patna, Bihar, India – 800008.
Ajros Pharmaceuticals operates in the healthcare industry, in the hospitals segment.
Ajros Pharmaceuticals can be reached at its registered office: Md Suleman Moola Sai Ki Bag, Patna, Bihar, India – 800008.

